Search for: "Glaxosmithkline PLC"
Results 41 - 60
of 203
Sort by Relevance
|
Sort by Date
2 Jul 2012, 11:57 am
In re Avandia Marketing, Sales Practices and Products Liability Litigation, No. 11-2664, decided June 28, 2012, the Third Circuit Court of Appeals reversed a district court decision (Eastern District of Pennsylvania)[2], which dismissed the claim of Humana Insurance Company (“Humana”) and other similarly situated providers of MAOs against GlaxoSmithKline, LLC and GlaxoSmithKline plc (collectively, “GSK”) for reimbursement of medical… [read post]
29 Jun 2012, 10:50 am
.'"IN RE: AVANDIA MARKETING, SALES PRACTICES and PRODUCTSLIABILITY LITIGATION GLAXOSMITHKLINE, LLC &GLAXOSMITHKLINE, PLC HUMANA MEDICAL PLAN, INC. and HUMANAINSURANCE COMPANY, individually and on behalf of all others similarlysituated, AppellantsNo. 11-2664UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT2012 U.S. [read post]
18 Jun 2012, 4:29 pm
In a 5-4 decision written by Justice Samuel Alito, the Supreme Court held that pharmaceutical sales representatives (PSRs) who were employed by GlaxoSmithKline PLC (Glaxo), formerly known as SmithKline Beecham Corp., were primarily engaged in “sales,” and therefore were properly classified as exempt under the FLSA’s outside sales exemption. [read post]
24 May 2012, 11:45 am
" Other pharmaceutical companies have also recently settled similar claims: Last November GlaxoSmithKline PLC, the maker of diabetes drug Avandia, said it would pay the U.S. government $3 billion to settle civil and criminal charges for illegally marketing Avandia. [read post]
15 May 2012, 3:12 pm
It also dropped a similar probe into GlaxoSmithKline after a U.S. rival Synthon withdrew its complaint". [read post]
11 May 2012, 2:09 pm
Oral arguments regarding GlaxoSmithKline PLC’s sales reps were heard before the Supreme Court just last month. [read post]
8 Apr 2012, 8:51 pm
• Defendants: Glaxosmithkline PLC; Stiefel Laboratories, Inc. [read post]
8 Mar 2012, 3:34 am
., GlaxoSmithKline PLC and others that have disclosed investigations for possible FCPA breaches. [read post]
25 Feb 2012, 10:04 am
GlaxoSmithKline PLC, 343 Fed.Appx. 671 (2d Cir. 2009) Baycol In re Baycol Prods. [read post]
15 Feb 2012, 7:00 am
Today, GlaxoSmithKline Plc settled nearly 25,000 cases about its Avandia diabetes drug in mediation as the multi-district litigation was winding down. [read post]
25 Jan 2012, 9:00 pm
., GlaxoSmithKline PLC, Boston Scientific Corp., Alcatel-Lucent SA and Verizon Wireless. [read post]
25 Jan 2012, 9:00 pm
., GlaxoSmithKline PLC, Boston Scientific Corp., Alcatel-Lucent SA and Verizon Wireless. [read post]
12 Jan 2012, 10:59 am
(which is now a fully-owned subsidiary of GlaxoSmithKline PLC, but at the time of the events in issue was the world’s largest private manufacturer of dermatology products) and its former chairman and CEO, Charles Stiefel. [read post]
4 Jan 2012, 6:01 pm
GlaxoSmithKline PLC agreed to pay $750 million to settle allegations involving false claims related to medications and adulterate drugs that didn’t satisfy FDA specification. $900 million came from drug companies accused of engaging in unlawful pricing to up their profits. [read post]
23 Dec 2011, 6:22 pm
GlaxoSmithKline PLC paid $750 million to settle civil and criminal charges that it purposely turned in, or caused to be submitted, false claims for adulterate drugs and medications that weren't in line with Food and Drug Administration specifications. [read post]
22 Dec 2011, 9:57 am
(Stiefel Labs), a subsidiary of GlaxoSmithKline PLC, and the company’s former chairman and chief executive officer Charles Stiefel with defrauding employees and company shareholders by allegedly making stock buybacks at significantly undervalued prices. [read post]
19 Dec 2011, 8:57 am
Additionally, GlaxoSmithKline PLC paid $750 million to resolve criminal and civil allegations that the company knowingly submitted, or caused to be submitted, false claims to government health care programs for adulterated drugs and for drugs that failed to conform with the strength, purity or quality specified by the Food and Drug Administration. [read post]
2 Dec 2011, 12:00 am
Supreme Court agreed to hear a case from the 9th Circuit on whether drug sales representatives of GlaxoSmithKline PLC are entitled to overtime pay under the Fair Labor Standards Act (FLSA). [read post]
15 Nov 2011, 7:30 am
Glaxo Facing Mediation Push to Resolve Avandia Lawsuits BusinessweekNovember 11, 2011 GlaxoSmithKline Plc, which has agreed to pay $3 billion to resolve claims it illegally marketed its Avandia diabetes drug, is facing a judge’s push to resolve most of the remaining patient lawsuits through court-ordered mediation. [read post]
4 Nov 2011, 4:09 am
GlaxoSmithKline PLC has agreed to pay the US government $3 billion to settle allegations that it violated marketing practices and may have defrauded Medicaid. [read post]
